Acetylcholinesterase (AChE) Reactivator Development and Approval Pipeline (ARDAP) Prototype
Due: March 27, 2024 Enhanced White Paper for FDA approval of an improved oxime in a vial to increase warfighter survivability. This opportunity requires membership in the MCDC Consortium. This Consortium releases numerous opportunities throughout the Read More